human airway smooth muscle (hasm) cells Search Results


96
ATCC human aortic smooth muscle cell hasmc strain
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Human Aortic Smooth Muscle Cell Hasmc Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic smooth muscle cell hasmc strain/product/ATCC
Average 96 stars, based on 1 article reviews
human aortic smooth muscle cell hasmc strain - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Kurabo industries human aortic smooth muscle cells
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Human Aortic Smooth Muscle Cells, supplied by Kurabo industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic smooth muscle cells/product/Kurabo industries
Average 90 stars, based on 1 article reviews
human aortic smooth muscle cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ScienCell human aorta smooth muscle cells hasmc
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Human Aorta Smooth Muscle Cells Hasmc, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aorta smooth muscle cells hasmc/product/ScienCell
Average 90 stars, based on 1 article reviews
human aorta smooth muscle cells hasmc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Kurabo industries hasmc ks4001
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Hasmc Ks4001, supplied by Kurabo industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hasmc ks4001/product/Kurabo industries
Average 90 stars, based on 1 article reviews
hasmc ks4001 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
PROVITRO GmbH human airway smooth muscle cells hasmc sc-3400
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Human Airway Smooth Muscle Cells Hasmc Sc 3400, supplied by PROVITRO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human airway smooth muscle cells hasmc sc-3400/product/PROVITRO GmbH
Average 90 stars, based on 1 article reviews
human airway smooth muscle cells hasmc sc-3400 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

99
ATCC crm ccl 185 d9 human airway smooth muscle cells a j
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Crm Ccl 185 D9 Human Airway Smooth Muscle Cells A J, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crm ccl 185 d9 human airway smooth muscle cells a j/product/ATCC
Average 99 stars, based on 1 article reviews
crm ccl 185 d9 human airway smooth muscle cells a j - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Hirschmann human airway smooth muscle cells
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Human Airway Smooth Muscle Cells, supplied by Hirschmann, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human airway smooth muscle cells/product/Hirschmann
Average 90 stars, based on 1 article reviews
human airway smooth muscle cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Lonza primary human airway smooth muscle cells (asmcs)
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Primary Human Airway Smooth Muscle Cells (Asmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human airway smooth muscle cells (asmcs)/product/Lonza
Average 90 stars, based on 1 article reviews
primary human airway smooth muscle cells (asmcs) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Thermo Fisher human aortic smooth muscle cells
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Human Aortic Smooth Muscle Cells, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic smooth muscle cells/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
human aortic smooth muscle cells - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Lonza human aortic smooth muscle cells (hasmc)
Mexo-P <t>regulates</t> <t>vascular</t> calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), <t>HASMC,</t> ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.
Human Aortic Smooth Muscle Cells (Hasmc), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic smooth muscle cells (hasmc)/product/Lonza
Average 90 stars, based on 1 article reviews
human aortic smooth muscle cells (hasmc) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Thermo Fisher human aortic smooth muscle cells hasmc
KEY RESOURCES TABLE
Human Aortic Smooth Muscle Cells Hasmc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic smooth muscle cells hasmc/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
human aortic smooth muscle cells hasmc - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
BioWhittaker Molecular Applications human aortic smooth muscle cells (hasmc)
KEY RESOURCES TABLE
Human Aortic Smooth Muscle Cells (Hasmc), supplied by BioWhittaker Molecular Applications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aortic smooth muscle cells (hasmc)/product/BioWhittaker Molecular Applications
Average 90 stars, based on 1 article reviews
human aortic smooth muscle cells (hasmc) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Mexo-P regulates vascular calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), HASMC, ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.

Journal: Cells

Article Title: High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease

doi: 10.3390/cells12010161

Figure Lengend Snippet: Mexo-P regulates vascular calcification in a let-7b-5p-dependent way. ( A ) Volcano plots show the result of miRNA sequencing between Mexo- and Mexo-P-treated MOVAS. ( B ) qRT-PCR validation of potential target miRNAs between Mexo- and Mexo-P-treated HASMCs (unpaired t -test, n = 5). ( C ) Expression levels of let-7b-5p in the artery tissue of mildly, moderately, or severely calcified CKD patients (unpaired t -test, n > 3). ARS staining ( D ) and calcium contents (( E ), one-way ANOVA, n = 4) of isolated mouse thoracic aortas, cultured in a calcifying medium (3 mM Pi) for 7 days, pretreated with let-7b-5p agomir or antagomir for 6 h. Representative images of ARS staining ( F ) and ARS quantification ( G ) of MOVAS treated with let-7b-5p-mimic or control (mimic-nc) and cultured in the calcifying medium for 7 days (Mann–Whitney test, n = 4). Representative images of ARS staining ( H ) and ARS quantification ( I ) of MOVAS treated with let-7b-5p-inhibitor or control (inhibitor-nc) and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( J ) and ARS quantification ( K ) of HASMCs treated with let-7b-5p-mimic or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Representative images of ARS staining ( L ) and ARS quantification ( M ) of MOVAS treated with let-7b-5p-inhibitor or control and cultured in the calcifying medium for 7 days (unpaired t -test, n = 4). Calcium content levels of calcifying-medium-cultured VSMCs (MOVAS, ( N ), HASMC, ( O )), stimulated with Mexo or Mexo-P in the presence or absence of let-7b-5p-mimic (one-way ANOVA, n = 4). * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.

Article Snippet: The mouse vascular smooth muscle (MOVAS) cell line (CRL-2797TM) and human aortic smooth muscle cell (HASMC) strain (PCS-100-012TM) were from American Type Culture Collection (ATCC, Rockville, MD, USA).

Techniques: Sequencing, Quantitative RT-PCR, Biomarker Discovery, Expressing, Staining, Isolation, Cell Culture, Control, MANN-WHITNEY

Let-7b-5p mitigates vascular calcification by regulating TGFBR1. ( A ) Volcano plots showing differentially regulated genes (DEGs) in RNA-seq of Mexo- and Mexo-P-treated MOVAS. ( B ) Venn diagram showing the intersection of miRBD-predicted potential let-7b-5p targets and DEGs. ( C ) mRNA levels of 10 potential target genes were detected by qRT-PCR in let-7b-5p-mimic- or mimic-nc-treated HASMCs (unpaired t -test, n > 3). ( D ) Transcription levels of four significantly regulated genes in ( C ) were detected in Mexo- or Mexo-P-treated HASMC (unpaired t -test, n > 3). ( E ) Representative images of ARS staining (bottom) and ARS quantification (top) of HASMCs, in which TGFBR1 and let-7b-5p levels were manipulated with TGFBR1 overexpression plasmid (TGFBR1-OE) or let-7b-5p-mimic treatment in calcifying medium (one-way ANOVA, n = 4). ( F ) Representative images of ARS staining (bottom) and ARS quantification (top) of HASMCs, in which TGFBR1 and let-7b-5p levels were manipulated with TGFBR1-si or let-7b-5p-mimic treatment in calcifying medium (one-way ANOVA, n = 4). Calcium content of HASMCs with altered TGFBR1 levels with TGFBR1-OE ( G ) or TGFBR1-si ( H ), with or without the treatment of let-7b-5p-mimic or let-7b-5p-inhibitor in calcifying medium (one-way ANOVA, n = 4). ( I ) Tergetscan database predicted binding sequences of let-7b-5p on TGFBR1-3′UTR. ( J ) Wildtype (wt) and two mutations (mut1 and mut2) of TGFBR1-3′UTR were inserted into luciferase vectors. Luciferase activity assay of HASMCs co-transfected with vectors carrying wt or mutated TGFBR1-3′UTR (mut1, ( K ), mut2, ( L )), renilla vectors, mimic-nc, or let-7b-5p-mimic for 6 h, medium change, and cultured for another 48 h before assay (two-way ANOVA, n > 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.

Journal: Cells

Article Title: High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease

doi: 10.3390/cells12010161

Figure Lengend Snippet: Let-7b-5p mitigates vascular calcification by regulating TGFBR1. ( A ) Volcano plots showing differentially regulated genes (DEGs) in RNA-seq of Mexo- and Mexo-P-treated MOVAS. ( B ) Venn diagram showing the intersection of miRBD-predicted potential let-7b-5p targets and DEGs. ( C ) mRNA levels of 10 potential target genes were detected by qRT-PCR in let-7b-5p-mimic- or mimic-nc-treated HASMCs (unpaired t -test, n > 3). ( D ) Transcription levels of four significantly regulated genes in ( C ) were detected in Mexo- or Mexo-P-treated HASMC (unpaired t -test, n > 3). ( E ) Representative images of ARS staining (bottom) and ARS quantification (top) of HASMCs, in which TGFBR1 and let-7b-5p levels were manipulated with TGFBR1 overexpression plasmid (TGFBR1-OE) or let-7b-5p-mimic treatment in calcifying medium (one-way ANOVA, n = 4). ( F ) Representative images of ARS staining (bottom) and ARS quantification (top) of HASMCs, in which TGFBR1 and let-7b-5p levels were manipulated with TGFBR1-si or let-7b-5p-mimic treatment in calcifying medium (one-way ANOVA, n = 4). Calcium content of HASMCs with altered TGFBR1 levels with TGFBR1-OE ( G ) or TGFBR1-si ( H ), with or without the treatment of let-7b-5p-mimic or let-7b-5p-inhibitor in calcifying medium (one-way ANOVA, n = 4). ( I ) Tergetscan database predicted binding sequences of let-7b-5p on TGFBR1-3′UTR. ( J ) Wildtype (wt) and two mutations (mut1 and mut2) of TGFBR1-3′UTR were inserted into luciferase vectors. Luciferase activity assay of HASMCs co-transfected with vectors carrying wt or mutated TGFBR1-3′UTR (mut1, ( K ), mut2, ( L )), renilla vectors, mimic-nc, or let-7b-5p-mimic for 6 h, medium change, and cultured for another 48 h before assay (two-way ANOVA, n > 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.

Article Snippet: The mouse vascular smooth muscle (MOVAS) cell line (CRL-2797TM) and human aortic smooth muscle cell (HASMC) strain (PCS-100-012TM) were from American Type Culture Collection (ATCC, Rockville, MD, USA).

Techniques: RNA Sequencing, Quantitative RT-PCR, Staining, Over Expression, Plasmid Preparation, Binding Assay, Luciferase, Activity Assay, Transfection, Cell Culture

Manipulating TGFBR1 levels regulates vascular calcification in CKD. Transcription levels of RUNX2, ALPL, and SOX9 in MOVAS ( A ) and HASMCs ( C ) stimulated with 10 ng/mL TGFβ1 for 24 h after being transfected with TGFBR1 siRNA for 6 h (one-way ANOVA, n > 3). mRNA levels of RUNX2, ALPL, and SOX9 in MOVAS ( B ) and HASMCs ( D ) stimulated with 10 ng/mL TGFβ1 for 24 h after being transfected with TGFBR1 overexpression plasmid (TGFBR1-OE) for 48 h (one-way ANOVA, n > 3). Representative WB images ( E ) and semi-quantification ( F ) showing RUNX2 levels in aortas from CKD mice injected with either Tgfbr1-adv or control (GFP-adv, unpaired t -test, n = 3). Representative images of ARS staining ( G ) and calcium content ( H ) of aortas from CKD mice injected with either Tgfbr1-adv or control (unpaired t -test, n > 3). ( I ) HASMCs were treated with SB525334 (1 μM), RepSOX (25 μM), and SB431542 (1 μM) for 6 h, after being transfected with SMAD3-luciferase plasmids for 24 h, and luciferase activity was detected (unpaired t -test, n = 3). ( J ) SMAD3-luciferase plasmid-transfected HASMCs were stimulated with 10 ng/mL TGFβ1 and different doses of SB525334 for 6 h, and luciferase activity was detected (one-way ANOVA, n > 3). ( K ) HASMCs were stimulated with 10 ng/mL TGFβ1 plus 1 μM SB525334 for 0, 3, 6, 12, 24, or 48 h, and RUNX2 mRNA levels were detected by qRT-PCR (one-way ANOVA, n = 5). In vitro calcification model showing the SB525334 (1 μM) inhibition of 10 ng/mL TGFβ1-induced HASMC calcification (( L ), ARS staining, ( M ), calcium content, one-way ANOVA, n = 6). Mice were orally administrated with 30 mg/kg SB525334 (n = 5) or vehicle (n = 5) daily; simultaneously with CKD modeling, aortas were collected for ARS staining ( N ), calcium content assay (( O ), unpaired t -test, n > 3), and Runx2, Alpl, and Sox9 mRNA levels detection (( P ), unpaired t -test, n > 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.

Journal: Cells

Article Title: High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease

doi: 10.3390/cells12010161

Figure Lengend Snippet: Manipulating TGFBR1 levels regulates vascular calcification in CKD. Transcription levels of RUNX2, ALPL, and SOX9 in MOVAS ( A ) and HASMCs ( C ) stimulated with 10 ng/mL TGFβ1 for 24 h after being transfected with TGFBR1 siRNA for 6 h (one-way ANOVA, n > 3). mRNA levels of RUNX2, ALPL, and SOX9 in MOVAS ( B ) and HASMCs ( D ) stimulated with 10 ng/mL TGFβ1 for 24 h after being transfected with TGFBR1 overexpression plasmid (TGFBR1-OE) for 48 h (one-way ANOVA, n > 3). Representative WB images ( E ) and semi-quantification ( F ) showing RUNX2 levels in aortas from CKD mice injected with either Tgfbr1-adv or control (GFP-adv, unpaired t -test, n = 3). Representative images of ARS staining ( G ) and calcium content ( H ) of aortas from CKD mice injected with either Tgfbr1-adv or control (unpaired t -test, n > 3). ( I ) HASMCs were treated with SB525334 (1 μM), RepSOX (25 μM), and SB431542 (1 μM) for 6 h, after being transfected with SMAD3-luciferase plasmids for 24 h, and luciferase activity was detected (unpaired t -test, n = 3). ( J ) SMAD3-luciferase plasmid-transfected HASMCs were stimulated with 10 ng/mL TGFβ1 and different doses of SB525334 for 6 h, and luciferase activity was detected (one-way ANOVA, n > 3). ( K ) HASMCs were stimulated with 10 ng/mL TGFβ1 plus 1 μM SB525334 for 0, 3, 6, 12, 24, or 48 h, and RUNX2 mRNA levels were detected by qRT-PCR (one-way ANOVA, n = 5). In vitro calcification model showing the SB525334 (1 μM) inhibition of 10 ng/mL TGFβ1-induced HASMC calcification (( L ), ARS staining, ( M ), calcium content, one-way ANOVA, n = 6). Mice were orally administrated with 30 mg/kg SB525334 (n = 5) or vehicle (n = 5) daily; simultaneously with CKD modeling, aortas were collected for ARS staining ( N ), calcium content assay (( O ), unpaired t -test, n > 3), and Runx2, Alpl, and Sox9 mRNA levels detection (( P ), unpaired t -test, n > 3). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant. Scale bar, 40 μM.

Article Snippet: The mouse vascular smooth muscle (MOVAS) cell line (CRL-2797TM) and human aortic smooth muscle cell (HASMC) strain (PCS-100-012TM) were from American Type Culture Collection (ATCC, Rockville, MD, USA).

Techniques: Transfection, Over Expression, Plasmid Preparation, Injection, Control, Staining, Luciferase, Activity Assay, Quantitative RT-PCR, In Vitro, Inhibition

TGFBR1 promotes vascular calcification through the SMAD3/RUNX2 pathway. qRT-PCR results showing that SIS-3 reversed TGFβ1-induced upregulation of RUNX2 levels in HASMCs ( A ) and MOVAS (( B ), one-way ANOVA, n = 5). Western blot images showing that different doses of SMAD3 inhibitor SIS-3 alleviated TGFβ1-induced RUNX2 level increase and SMAD2/3 phosphorylation in HAMSCs ( C ) and MOVAS ( D ). ( E ) The JASPAR database predicted the binding site of SMAD3 on RUNX2 promoter, and the mutation was generated. ( F ) HASMCs were transfected with Renilla plasmid, wildtype RUNX2-promoter luciferase plasmid, and different doses of SMAD3-OE plasmid for 24 h, and luciferase activity was detected (one-way ANOVA, n = 5). ( G ) HASMC was transfected with Renilla plasmid, SMAD3-OE plasmid (3 ng per well of 12-well plate), and wildtype (wt) or mutated (mut) RUNX2-promoter luciferase plasmid, and luciferase activity was detected (Mann–Whitney test, n = 6). ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.

Journal: Cells

Article Title: High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease

doi: 10.3390/cells12010161

Figure Lengend Snippet: TGFBR1 promotes vascular calcification through the SMAD3/RUNX2 pathway. qRT-PCR results showing that SIS-3 reversed TGFβ1-induced upregulation of RUNX2 levels in HASMCs ( A ) and MOVAS (( B ), one-way ANOVA, n = 5). Western blot images showing that different doses of SMAD3 inhibitor SIS-3 alleviated TGFβ1-induced RUNX2 level increase and SMAD2/3 phosphorylation in HAMSCs ( C ) and MOVAS ( D ). ( E ) The JASPAR database predicted the binding site of SMAD3 on RUNX2 promoter, and the mutation was generated. ( F ) HASMCs were transfected with Renilla plasmid, wildtype RUNX2-promoter luciferase plasmid, and different doses of SMAD3-OE plasmid for 24 h, and luciferase activity was detected (one-way ANOVA, n = 5). ( G ) HASMC was transfected with Renilla plasmid, SMAD3-OE plasmid (3 ng per well of 12-well plate), and wildtype (wt) or mutated (mut) RUNX2-promoter luciferase plasmid, and luciferase activity was detected (Mann–Whitney test, n = 6). ** p < 0.01, *** p < 0.001, **** p < 0.0001, n.s. not significant.

Article Snippet: The mouse vascular smooth muscle (MOVAS) cell line (CRL-2797TM) and human aortic smooth muscle cell (HASMC) strain (PCS-100-012TM) were from American Type Culture Collection (ATCC, Rockville, MD, USA).

Techniques: Quantitative RT-PCR, Western Blot, Phospho-proteomics, Binding Assay, Mutagenesis, Generated, Transfection, Plasmid Preparation, Luciferase, Activity Assay, MANN-WHITNEY

KEY RESOURCES TABLE

Journal: Cell stem cell

Article Title: Smooth muscle cell reprogramming in aortic aneurysms

doi: 10.1016/j.stem.2020.02.013

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Human: Aortic Smooth Muscle Cells (HASMC) , ThermoFisher SCIENTIFIC , C0075C.

Techniques: Recombinant, Multiplex Assay, Staining, In Situ, Marker, Expressing, Plasmid Preparation, shRNA, Software